Figure 3 | Scientific Reports

Figure 3

From: Effects of rifampin on the pharmacokinetics and pharmacodynamics of milvexian, a potent, selective, oral small molecule factor XIa inhibitor

Figure 3

Effect of rifampin on milvexian PK parameters. PK, pharmacokinetic; GMR, geometric mean ratio; CI, confidence interval; Cmax, maximum observed plasma concentration; AUC(0–T), area under the plasma concentration–time curve from time 0 to time of last quantifiable concentration; AUC(INF), area under the concentration–time curve from time 0 extrapolated to infinite time.

Back to article page